Artificial Intelligence (AI) is rapidly moving from experimentation to practical application in regulatory operations, but adoption must be handled with care. This fireside chat webinar explores how AI is being applied today to support submission readiness, improve content consistency, and reduce timelines, without compromising quality, compliance, or regulatory confidence.
Drawing on practical experience, we’ll discuss where AI is delivering the most immediate value, how organizations are integrating AI alongside expert oversight, and what it takes to implement AI responsibly in highly regulated environments.
This session is designed for regulatory leaders and operational teams looking to move beyond hype and gain perspectives on what works, and what to consider before scaling AI across regulatory workflows.
Speakers
- Lucy Sutton – Vice President, Account Management
- Ben Kaspar – Vice President, Regulatory Strategy
Watch This Webinar To:
- Understand where AI is already delivering measurable impact across regulatory operations
- Explore how AI supports content development, reuse, and consistency across submissions
- Learn how organizations are augmenting regulatory teams with AI while maintaining control and accountability
- Identify key governance, validation, and risk considerations for regulated AI use
- Gain insight into how regulatory operations is evolving toward more agentic, workflow-driven models
What You Will Learn:
- Practical AI use cases that accelerate submission readiness today
- How AI can improve efficiency without eroding quality or regulatory oversight
- Approaches for balancing automation with expert judgment in regulatory work
- Governance and validation considerations for deploying AI in regulated environments
- Where AI in regulatory operations is heading and how to prepare for what’s next
Topics We’ll Explore:
- Where AI is delivering the most immediate impact today, without compromising quality, compliance, or traceability
- The role of AI in streamlining content development, reuse, and consistency across regulatory documents
- Emerging approaches to augmenting regulatory teams with AI, balancing automation with expert oversight
- Key considerations for implementing AI in regulated environments, including governance, validation, and risk management
- The future of AI in regulatory operations, including the shift toward more agentic and workflow-driven solutions
Who Will Benefit From Attending?
- Regulatory Affairs and Regulatory Operations teams
- Medical Writing and Submission Management professionals
- Clinical Development and Program Strategy leaders
- Quality, Compliance, and Governance stakeholders
- Biotech and pharmaceutical teams preparing or scaling regulated AI initiatives
FAQs
- Will a recording be available? – Yes. A recording will be shared with all registered attendees following the live session.
- Who should attend this webinar? – This session is designed for regulatory and clinical development professionals seeking a clear, practical understanding of how AI is being applied responsibly across regulatory operations today.
Register Now
Suggested For You
webinar
March 26th, 2026
Making the Right Decisions With Incomplete Evidence in Early-Phase Oncology Trials
webinar
April 30th, 2026
Inside FDA REMS Decision-Making: A Fireside Chat for Sponsors
webinar
January 29th, 2026
Technology Use Cases: Shaping the Future of Trial Design and Implementation
webinar
December 4th, 2025
Writing with Quality Control in Mind: A Cross-functional Approach
webinar
June 26th, 2025
De-Risking Development with Specialized Data Strategies: From Trial Design to Submission
webinar
October 21st, 2025
A Practical Guide to Expedited Regulatory Pathways
webinar
September 25th, 2025
The Psychedelic Inflection Point: What Sponsors Need to Know Now
webinar
August 28th, 2025
Shaping the Future of AI-Enabled Medical Writing
webinar
July 31st, 2025
Design, Data, and Decisions in Oncology Trials
webinar
April 30th, 2025
Advancing Clinical Development with Innovative Trial Design and Regulatory Strategies
webinar
March 25th, 2025
Overcoming NDA/BLA Submission Challenges: Practical Strategies for Success
webinar
October 22nd, 2024
Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules